Cryptocurrency trading, especially altcoin trading, is inherently risky due to its experimental nature and the high volatility in the crypto market. Understanding which altcoins to avoid is a crucial part of a good risk management strategy. Indicators such as the Relative Strength Index (RSI), structural changes, supply inflation, token unlock events, and demand projections can provide valuable information and warning signs.
In February 2023, the New York Department of Financial Services ordered Paxos to stop issuing Binance USD (BUSD), following a lawsuit against Binance, Paxos’ issuance partner. Binance assured that BUSD could be fully redeemed until at least February 2024, but the situation post-February remains uncertain, prompting investors to steer clear of BUSD.
Injective (INJ) is expected to face significant selling pressure as the unlocking period for vested tokens will release over $125 million worth of INJ. The total amount to be released exceeds $135 million, which could lead to heavy sales in the coming week, making it advisable for investors to be cautious with INJ.
Kaspa (KAS), a relatively new altcoin that has shown impressive price performance, is the third altcoin to avoid in the short term. Despite its rise from $0.000170 in May 2022 to an all-time high of $0.155 in November 2023, Kaspa has experienced a supply inflation of 163% since June 2022. With the current circulating supply of 22.37 billion KAS not yet fully priced in, KAS’s high supply inflation poses a risk for investors.
These three altcoins present potential risks based on regulatory actions, token unlocks, and supply inflation, making them less attractive for short-term investment. Investors are advised to conduct thorough research and exercise caution when considering these altcoins.
